Skip to main content

and
  1. Article

    Open Access

    Impact of a simulation-based education approach for health sciences: demo, debrief, and do

    Skill-based practice (e.g., communication skills) is important for individuals to incorporate into students' learning and can be challenging in large classes. Simulation-based education (SBE) is a method where...

    Elizabeth Orsega-Smith, Tara Leonard, Laurie Ruggiero in BMC Medical Education (2023)

  2. Article

    Open Access

    Burden and Treatment of Achondroplasia: A Systematic Literature Review

    Achondroplasia is the most common form of skeletal dysplasia. Recent advances in therapeutic options have highlighted the need for understanding the burden and treatment landscape of the condition. This system...

    Molly C. Murton, Emma L. A. Drane, Danielle M. Goff-Leggett in Advances in Therapy (2023)

  3. Article

    Open Access

    Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart review

    Haemophilia A is a bleeding disorder caused by deficiency of coagulation factor VIII (FVIII) which leads to severe and repeated bleedings. There is a need to understand the optimal treatment pathway for FVIII ...

    George Morgan, Emily Back, Doug Rosa, Jamie O’Hara in Orphanet Journal of Rare Diseases (2023)

  4. Article

    Open Access

    Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting

    Long-term prophylactic therapy is considered the standard of care for hemophilia A patients. This study models the long-term clinical and cost outcomes of two factor VIII (FVIII) products using a pharmacokinet...

    Rong Chen, Dmitry Gultyaev, Johanna Lister, Rong Han in BMC Medical Research Methodology (2022)

  5. Article

    Open Access

    Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study

    Haemophilia bears substantial humanistic and economic burden on children and their caregivers. Characterising the differential impact of severe versus moderate paediatric haemophilia is important for clinical ...

    Idaira Rodriguez-Santana, Pronabesh DasMahapatra in Orphanet Journal of Rare Diseases (2022)

  6. Article

    Open Access

    Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study

    The lifelong nature of haemophilia makes patient-centred and societal assessments of its impact important to clinical and policy decisions. Quantifying the humanistic and economic burden by severity is key to ...

    Idaira Rodriguez-Santana, Pronabesh DasMahapatra in Orphanet Journal of Rare Diseases (2022)

  7. Article

    Open Access

    Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe

    Real-world studies of the burden of severe haemophilia B in the context of recent therapeutic advances such as extended half-life (EHL) factor IX (FIX) products are limited. We analysed data from the recent CH...

    Tom Burke, Sohaib Asghar, Jamie O’Hara in Orphanet Journal of Rare Diseases (2021)

  8. Article

    Open Access

    Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys

    Hemophilia B is a rare congenital bleeding disorder that has a significant negative impact on patients’ functionality and health-related quality of life. The standard of care for severe hemophilia B in the Uni...

    Tom Burke, Sohaib Asghar, Jamie O’Hara in Orphanet Journal of Rare Diseases (2021)

  9. Article

    Open Access

    Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis

    Untreated hemophilia A patients may experience recurrent bleeding events leading to debilitating joint damages. While RCT and pharmacokinetic data support the value of Kovaltry [an unmodified full-length recom...

    Jamie O’Hara, Ceri Hirst, Jose Francisco Cabre Marquez in Orphanet Journal of Rare Diseases (2021)

  10. Article

    Open Access

    Inhibitor clinical burden of disease: a comparative analysis of the CHESS data

    Patients with hemophilia and inhibitors generally face greater disease burden compared to patients without inhibitors. While raising awareness of relative burden may improve the standard of care for patients w...

    Abiola O. Oladapo, Mei Lu, Shaun Walsh, Jamie O’Hara in Orphanet Journal of Rare Diseases (2018)

  11. Article

    Open Access

    The impact of severe haemophilia and the presence of target joints on health-related quality-of-life

    Joint damage remains a major complication associated with haemophilia and is widely accepted as one of the most debilitating symptoms for persons with severe haemophilia. The aim of this study is to describe h...

    Jamie O’Hara, Shaun Walsh, Charlotte Camp in Health and Quality of Life Outcomes (2018)

  12. Article

    Open Access

    The relationship between target joints and direct resource use in severe haemophilia

    Target joints are a common complication of severe haemophilia. While factor replacement therapy constitutes the majority of costs in haemophilia, the relationship between target joints and non drug-related dir...

    Jamie O’Hara, Shaun Walsh, Charlotte Camp, Giuseppe Mazza in Health Economics Review (2018)

  13. Article

    Open Access

    The cost of severe haemophilia in Europe: the CHESS study

    Severe haemophilia is associated with major psychological and economic burden for patients, caregivers, and the wider health care system. This burden has been quantified and documented for a number of European...

    Jamie O’Hara, David Hughes, Charlotte Camp, Tom Burke in Orphanet Journal of Rare Diseases (2017)

  14. Article

    Open Access

    Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany

    Friedreich’s Ataxia (FRDA) is a neurodegenerative disorder that causes progressive damage to the central and peripheral nervous systems having a significant impact upon quality of life. With little information...

    Paola Giunti, Julia Greenfield, Alison J Stevenson in Orphanet Journal of Rare Diseases (2013)